In agreement with previous reports, we also demonstrated that the proportion of cases with detectable cfDNA KRAS mutations tended to increase with more advanced stages and that KRAS allelic fractions were higher in cases than controls or in patients with chronic pancreatitis [23, 26]. Here, KRAS is linked to chronic pancreatitis.